Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MTBVAC Vaccine Against Tuberculosis in Adolescents and Adults
NCT06272812Phase 2Active, not recruiting
- Sponsor
- International AIDS Vaccine Initiative
- Start
- Feb 2025
- Primary completion
- Dec 2028
- Modality
- Live Biotherapeutic Products, Vaccines & Immunotherapeutics
- Countries
- 3
01
Overview
A Phase 2 trial of mtbvac in Tuberculosis (TB), sponsored by International AIDS Vaccine Initiative. Started Feb 2025; status: active, not recruiting.
02
Drugs
mtbvac
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT06272812.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06272812.